Edetate calcium disodium
- Generic Name
- Edetate calcium disodium
- Brand Names
- Calcium Disodium Versenate
- Drug Type
- Small Molecule
- Chemical Formula
- C10H12CaN2Na2O8
- CAS Number
- 62-33-9
- Unique Ingredient Identifier
- 8U5D034955
- Background
Edetate calcium disodium is a metal ion chelator used to reduce blood concentrations and depot stores of lead from the body. It is on the World Health Organization Model List of Essential Medicines.
Edetate calcium disodium was granted FDA approval on 16 July 1953.
- Indication
Edetate calcium disodium is indicated to reduce blood levels and depot stores of lead in acute and chronic lead poisoning.
- Associated Conditions
- Lead Poisoning
- Associated Therapies
- -
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
Phase 1
Recruiting
- Conditions
- Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveHigh Risk Myelodysplastic SyndromeMyeloproliferative NeoplasmRefractory Acute Myeloid LeukemiaSecondary Acute Myeloid LeukemiaAcute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeVery High Risk Myelodysplastic SyndromeChronic Myelogenous Leukemia, BCR-ABL1 PositiveMyelodysplastic Syndrome
- Interventions
- First Posted Date
- 2018-08-15
- Last Posted Date
- 2024-06-25
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 58
- Registration Number
- NCT03630991
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Prolonged Gadolinium Retention After MRI Imaging
- First Posted Date
- 2015-04-20
- Last Posted Date
- 2017-08-29
- Lead Sponsor
- Mt. Sinai Medical Center, Miami
- Registration Number
- NCT02421029
- Locations
- 🇺🇸
Mount Sinai Medical Center, Miami Beach, Florida, United States
Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies
Phase 1
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2010-04-12
- Last Posted Date
- 2013-02-15
- Lead Sponsor
- M.D. Anderson Cancer Center
- Registration Number
- NCT01101412
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath